DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+15%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.15B
AUM Growth
+$2.15B
(-15%)
Cap. Flow
-$626M
Cap. Flow
% of AUM
-29.09%
Top 10 Holdings %
Top 10 Hldgs %
42.88%
Holding
121
New
14
Increased
12
Reduced
29
Closed
26
Top Buys
| 1 |
NVRO
NEVRO CORP.
NVRO
|
$56M |
| 2 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$44.6M |
| 3 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$25M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
$24.3M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
$19.4M |
Top Sells
Sector Composition
| 1 | Healthcare | 70.12% |
| 2 | Financials | 3.34% |
| 3 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Cigna
CI
$80.2B
| – | – |
-171,000
| Closed | -$21.9M |
|
102
CareDx
CDNA
$678M
| – | – |
-51,204
| Closed | -$221K |
|
103
Alphatec Holdings
ATEC
$2.35B
| – | – |
-4,982,738
| Closed | -$1.75M |
|
104
Arcturus Therapeutics
ARCT
$467M
| – | – |
-1,069,914
| Closed | -$4.8M |
|
105
Alnylam Pharmaceuticals
ALNY
$58.6B
| – | – |
-336,000
| Closed | -$18.6M |
|
106
Aldeyra Therapeutics
ALDX
$350M
| – | – |
-267,764
| Closed | -$1.52M |
|
|
RLYP
107
DELISTED
RELYPSA INC COM
RLYP
| – | – |
-1,670,383
| Closed | -$30.9M |
|